Matthew Norkunas
Financieel Directeur/CFO bij GENERATION BIO CO.
Vermogen: 158 392 $ op 30-04-2024
Actieve functies van Matthew Norkunas
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GENERATION BIO CO. | Comptroller/Controller/Auditor | 22-07-2020 | - |
Financieel Directeur/CFO | 22-07-2020 | - | |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 23-05-2023 | - |
Loopbaan van Matthew Norkunas
Eerdere bekende functies van Matthew Norkunas
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Financieel Directeur/CFO | 01-01-2016 | 01-06-2020 |
Marsico Capital Management LLC
Marsico Capital Management LLC Investment ManagersFinance Marsico Capital Management LLC (MCM) is a SEC-registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded by Thomas “Tom” Marsico in 1997. MCM manages assets for mutual funds, corporate retirement plans, endowments, foundations, family offices, separately managed wrap programs, and other clients. The firm also serves as the investment adviser to the Marsico Funds. | Analyst-Equity | 01-07-2012 | - |
Opleiding van Matthew Norkunas
St. Mary's College (Maryland) | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
University of Maryland School of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Director of Finance/CFO | 2 |
Analyst-Equity | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENERATION BIO CO. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Marsico Capital Management LLC
Marsico Capital Management LLC Investment ManagersFinance Marsico Capital Management LLC (MCM) is a SEC-registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded by Thomas “Tom” Marsico in 1997. MCM manages assets for mutual funds, corporate retirement plans, endowments, foundations, family offices, separately managed wrap programs, and other clients. The firm also serves as the investment adviser to the Marsico Funds. | Finance |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Matthew Norkunas
- Ervaring